Lead Authors
Diane McIntosh, BSc (Pharm), MD, FRCPC
Psychiatrist, Clinical Assistant Professor, University of British Columbia
Board member, Canadian Network for Mood and Anxiety Treatments (CANMAT)
Ric M. Procyshyn, BSc (Pharm), MSc, PharmD, PhD
Clinical Professor, Psychiatry, University of British Columbia Psychopharmacologist Principal Editor, Clinical Handbook of Psychotropic Drugs Co-Editor, Clinical Handbook of Psychotropic Drugs for Children and Adolescents
Other Contributors
David Attwood, MD, FRCPC — Expert Reviewer
Psychiatrist, Clinical Chief
Mental Health and Addictions, Eastern Health Clinical Assistant Professor of Psychiatry Memorial University of Newfoundland
Alasdair M Barr, PhD — Expert Reviewer
Associate Professor, Department of Pharmacology, Faculty of Medicine, University of British Columbia
David Bloom, MD, FRCPC — Expert Reviewer
Medical Chief, Intellectual Handicap with Pyschiatric Comorbidity Program
Medical Chief, Psychotic Disorders Program
Associate professor, Department of Psychiatry, McGill University, Montreal
William Honer, MD, FRCPC — Expert Reviewer
Jack Bell Chair in Schizophrenia
Professor and Head, Department of Psychiatry Director, Institute of Mental Health University of British Columbia
Raymond W. Lam, MD, FRCPC — Expert Reviewer
Professor, Department of Psychiatry, University of British Columbia
Director, Mood Disorders Centre of Excellence, UBC Hospital, Vancouver
Executive Chair, Canadian Network for Mood and Anxiety Treatments
Ayal Schaffer, MD, FRCPC — Expert Reviewer
Head of the Mood Disorders Program Sunnybrook Health Sciences Centre Assistant
Professor, Department of Psychiatry, University of Toronto
Allan Young, MBChB, MPhil, PhD, FRCPsych (UK) — Expert Reviewer
Chair and Head of Psychiatry, Imperial College London, UK.